Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 9, 2019
IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development
Matthew T Stier, Ramkrishna Mitra, Lindsay E Nyhoff, et al.
The Journal of Allergy and Clinical Immunology
|
May 9, 2016
Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
Matthew T Stier, Melissa H Bloodworth, Shinji Toki, et al.
Gastroenterology
|
September 6, 2020
Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach
Anne R Meyer, Amy C Engevik, Toni Madorsky, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2018
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
Shinji Toki, Kasia Goleniewska, Sara Reiss, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 18, 2015
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses
Weisong Zhou, Shinji Toki, Jian Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Critical illness expands a transcriptionally distinct hypometabolic CD8 <sup>+</sup> T effector program associated with respiratory failure and mortality
Casey M Nichols, Erin L Mwizerwa, Chooi Ying Sim, et al.
Cell Reports
|
November 30, 2017
Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
Jacqueline-Yvonne Cephus, Matthew T Stier, Hubaida Fuseini, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis
Matthew T Stier, Allison E Sewell, Erin L Mwizerwa, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology
Melissa H Bloodworth, Mark Rusznak, Connor C Pfister, et al.
Science Advances
|
March 31, 2023
Immune characterization of a xenogeneic human lung cross-circulation support system
Wei K Wu, Matthew T Stier, John W Stokes, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Journal of Immunology (Baltimore, Md. : 1950)
|
August 9, 2019
IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development
Matthew T Stier, Ramkrishna Mitra, Lindsay E Nyhoff, et al.
The Journal of Allergy and Clinical Immunology
|
May 9, 2016
Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin
Matthew T Stier, Melissa H Bloodworth, Shinji Toki, et al.
Gastroenterology
|
September 6, 2020
Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach
Anne R Meyer, Amy C Engevik, Toni Madorsky, et al.
The Journal of Allergy and Clinical Immunology
|
January 15, 2018
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
Shinji Toki, Kasia Goleniewska, Sara Reiss, et al.
American Journal of Respiratory and Critical Care Medicine
|
September 18, 2015
Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses
Weisong Zhou, Shinji Toki, Jian Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Critical illness expands a transcriptionally distinct hypometabolic CD8 <sup>+</sup> T effector program associated with respiratory failure and mortality
Casey M Nichols, Erin L Mwizerwa, Chooi Ying Sim, et al.
Cell Reports
|
November 30, 2017
Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation
Jacqueline-Yvonne Cephus, Matthew T Stier, Hubaida Fuseini, et al.
Biorxiv : the Preprint Server for Biology
|
February 20, 2025
Metabolic Adaptations Rewire CD4 T Cells in a Subset-Specific Manner in Human Critical Illness with and without Sepsis
Matthew T Stier, Allison E Sewell, Erin L Mwizerwa, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2018
Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology
Melissa H Bloodworth, Mark Rusznak, Connor C Pfister, et al.
Science Advances
|
March 31, 2023
Immune characterization of a xenogeneic human lung cross-circulation support system
Wei K Wu, Matthew T Stier, John W Stokes, et al.
Page
of 3